Figure 4.
Kaplan-Meier survival analysis in 95 patients of WHO II–IV grade gliomas, according to the CD163 immunohistochemical expression. (A) Correlation of OS with CD163 levels according to a four-category (0, 1, 2, 3) scoring system. (B) Correlation of OS with CD163 levels according to a two-category (low and high) scoring system. The log-rank test was performed to determine statistical significance, with P<0.05 considered as significant. OS, overall survival; CD, cluster of differentiation; WHO, World Health Organization.